Jove
Visualize
Contact Us

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cellular Differentiation00:57

Cellular Differentiation

How does a complex organism such as a human develop from a single cell? It all starts from a single fertilized egg which gives rise to a vast array of cell types, such as nerve cells, muscle cells, and epithelial cells that characterize the adult? Throughout development and adulthood, cellular differentiation leads cells to assume their final morphology and physiology. Differentiation is the process by which unspecialized cells become specialized to carry out distinct functions.
A zygote is a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Correction: Jaramillo-Valverde <i>et al</i>. Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in Peru. 2025; 17(3): 40566.

Frontiers in bioscience (Scholar edition)·2026
Same journal

Sex-Dependent Association of <i>SMAD3</i> Gene Polymorphisms With Asthma and Allergy Risk in Russian Children.

Frontiers in bioscience (Scholar edition)·2026
Same journal

The Role of the Microbiome in the Development of an Autoimmune Reaction in Rheumatoid Arthritis.

Frontiers in bioscience (Scholar edition)·2026
Same journal

Genomic Analysis Revealed Hotspots of Genetic Adaptation and Risk of Disappearance in Brazilian Goat Populations.

Frontiers in bioscience (Scholar edition)·2026
Same journal

Circulating MicroRNAs and Clinical Parameters in Hypertrophic Cardiomyopathy: A Systematic Review and Correlation Meta-Analysis.

Frontiers in bioscience (Scholar edition)·2026
Same journal

Looking at Optic Nerve Sheath Meningiomas Through Genetics-From Clinic to Bench and Back Again.

Frontiers in bioscience (Scholar edition)·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 21, 2026

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells
09:32

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells

Published on: February 27, 2020

Endogenous anticancer mechanism: differentiation.

Miriam Bianchi de Frontin Werneck1

  • 1Brazilian National Institute of Cancer (INCA), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, RJ, Brazil. meiwerneck@gmail.com

Frontiers in Bioscience (Scholar Edition)
|June 2, 2012
PubMed
Summary

Cancer stem-like cells (CSCs) drive tumor growth and relapse due to their self-renewal capacity and resistance to therapy. Understanding CSCs is key to developing new cancer treatments that target these cells for differentiation.

More Related Videos

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Related Experiment Videos

Last Updated: May 21, 2026

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells
09:32

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells

Published on: February 27, 2020

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Area of Science:

  • Oncology
  • Cancer Biology
  • Stem Cell Research

Background:

  • A small subpopulation of cancer cells, known as cancer stem-like cells (CSCs), possess self-renewal and tumor regeneration capabilities.
  • CSCs share characteristics with normal stem cells, including gene expression, proliferation, and surface markers, identifying them as tumor-initiating cells (TICs).
  • The limited susceptibility of CSCs to conventional therapies contributes to high rates of cancer treatment relapse.

Purpose of the Study:

  • To review the cancer stem cell (CSC) theory and its implications in cancer biology.
  • To discuss signaling pathways crucial for maintaining CSC undifferentiated and pluripotent states.
  • To explore novel therapeutic strategies targeting CSCs in modern cancer treatment.

Main Methods:

  • This review synthesizes current literature on cancer stem cell biology.
  • It examines signaling pathways implicated in CSC self-renewal and survival.
  • It discusses emerging therapeutic approaches aimed at CSC differentiation.

Main Results:

  • CSCs are identified as key drivers of tumor initiation, growth, and therapeutic resistance.
  • Specific signaling pathways are crucial for maintaining the stemness and pluripotency of CSCs.
  • Targeting CSCs offers a promising avenue for overcoming treatment resistance and preventing relapse.

Conclusions:

  • The CSC theory provides a framework for understanding tumor heterogeneity and therapeutic challenges.
  • Elucidating CSC-specific pathways is essential for developing effective cancer therapies.
  • Targeting CSCs for differentiation represents a significant advancement in cancer treatment strategies.